4.50
+0.90%
Close of 9 Nov 2026, in THB
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Healthlead PCL
Its shares trade on SET under the ticker HL.BK. It has been listed since 3 December 2021. In the fiscal year to 31 December 2025, it reported revenue of THB 2.23bn and net income of THB 77.9m. At that date it held total assets of THB 1.60bn and shareholders' equity of THB 967.6m.
Healthlead PCL is a holding company, which engages in the provision of pharmacy businesses, distribution of medicine, medical supplies, cosmeceuticals, dietary supplements, medical equipment, and various health products. The company is headquartered in Nonthaburi, Nonthaburi. The company went IPO on 2021-12-03. The principal businesses of the Company and its subsidiaries include pharmacy business distributing medicines, medical supplies, cosmeceuticals, supplements, medical devices, and other healthcare products as well as in business regarding invention business, developing, importing, and distributing healthcare products. The company operates pharmacies under four brands namely Icare, Pharmax, vitaminclub, and Super Drug. The firm sells more than 10,000 stock-keeping units (SKUs) of medical supplies, cosmeceuticals, dietary supplements, medical equipment, and healthcare products via these pharmacies in response to customers’ various needs. Its pharmacies feature medicines, dietary supplements, medical equipment, household utensils, external healthcare products, and consumer goods. Its PRIME brand is a dietary supplement product, which includes PRIME Hibiki Collagen Pure and PRIME Acerola Cherry Extract 1200 MG.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 3 Dec 2021
- Employees
- 484
- Website
- healthleadgroup.com ↗
Leadership
Pay as last reported
- Asst. Prof. Apirudee HemajutaNon-Executive Independent Chairman of the BoardTHB 100,000
- Pol. Capt. Thatchaphon ChonwattanasakulChief Executive Officer, Acting Chief Business Development Officer, Acting IT Director, Executive Director, since 2018
- Mrs. Araya TantanasinChief Financial Officer, Company Secretary
- Ms. Tatim PrakitnonthakarnFinance Director
- Mr. Supakorn BhandhukanondaChief Operating Officer, Executive Director, since 2018
- Ms. Jariya KwanjareonAccounting Director
- Ms. Mataya BhandhukanondaExecutive Director, since 2018
- Ms. Pattarawan SiripongvilaiMarketing and Sales Promotion Director
- Ms. Bussakorn AmphankaoHuman Resource Director
- Mr. Ponnathuch TongsukmakOperations Director
- Mr. Rathpong RatanahirunyaIndependent Director
- Mr. Thanasak KulrattanarakNon-Executive Independent DirectorTHB 100,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company is a holding company engaged in pharmacy businesses and distribution of healthcare products.
- Operates under four pharmacy brands including Icare, Pharmax, vitaminclub, and Super Drug.
- Sells over 10,000 SKUs of healthcare products across its pharmacy network.
Weaknesses
- Source description is treated as untrusted facts and not to be followed.
- No specific financial data or performance metrics provided in the description.
- No information on market share or competitive positioning within the retail sector.
Opportunities
- Expansion of product range through PRIME brand dietary supplements.
- Growth potential in the healthcare product distribution market in Thailand.
- Potential for increased market share through existing pharmacy brands and SKUs.
Threats
- Reliance on untrusted source description for factual information.
- Lack of detailed financial data may hinder investor confidence.
- Competition in the retail and healthcare product distribution sector.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.